Penn microbiologist recognized for groundbreaking microbiome research SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that the winner of the 2018 Agilent Early Career Professor Award is Christoph Thaiss, Ph.D., assistant professor of microbiology in the Perelman School of Medicine at the University of Pennsylvania. Dr. Thaiss's research focuses on the microbiome and how [...]

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific: "The sale of our Advanced Bioprocessing business will create greater focus for our Life Sciences segment where BD has outstanding opportunities to contribute significant [...]

Providing a best-in-class solution for immuno-oncology research, from RNA extraction to comprehensive data analysis, to advance therapeutic developmentSOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to accelerate the development of checkpoint immunotherapies and the identification of potential predictive biomarker signatures for therapeutic response. The integrated solution for [...]

10 years after SOPRA (acquired in 2008) exited the Semiconductor market, Semilab is getting back in business with its second generation μSE tools. Semilab's μSE Series are state-of-the-art, cost effective ellipsometers addressing Semiconductor More-than-Moore, III-V (GaN, InGaAs….), Micro (O)LED markets. With more than 30 years of experience in ellipsometry, Semilab is offering an extensive library [...]

Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer reviewed Phase 1 SBIR grant from NIH NCATS titled: “Digital representation of chemical mixtures to aid drug discovery and formulation”. InChI provides a concise, canonical, and unique summary of a compound rather than a [...]

Antibodies.com appoints new CEO Antibodies.com has appointed Dr Claire Button as its new Chief Executive Officer. This appointment marks a step change in growth strategy as Antibodies.com aims to become the market leader for protein research tools. Dr Button, who holds a PhD in Immunopharmacology, has spent the last decade partnering with life science ventures [...]

NEWARK, Calif.--Bioengineering company ATUM announces today that it has extended its 2014 agreement with Archer Daniels Midland Company (NYSE: ADM) to apply ATUM’s proprietary bioengineering technology and gene engineering platform to ADM’s process technologies. “We are extremely excited to continue working with global leader ADM,” said Claes Gustafsson, ATUM Chief Commercial Officer. “Our proprietary bioengineering [...]

European Immuno-Oncology Consortium to present update on TMB standardization efforts and clinical research data derived from new Oncomine Tumor Mutation Load Assay workflow CARLSBAD, Calif. -- Thermo Fisher Scientific will host a symposium featuring customer presentations that highlight the latest efforts in tumor mutation burden (TMB) standardization by its European consortium, and clinical research data focused on [...]

ORLANDO, FLA – Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to increase capacity for its novel human-on-a-chip technology, and prepare its systems for regulatory approval utilizing advanced PKPD [...]

WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has signed a definitive agreement with BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This business combines a strong technical services program with a [...]